


We’re not yet accepting patients, but you can learn about our approach or join our early access list.
The Doctor’s Pharmacy is a UK-based, clinician-led medical service focused on evidence-based weight management and metabolic health. Care is designed around structured medical assessment, ongoing review, and — where appropriate — prescription treatment delivered remotely.
This service is intended for adults seeking medically supervised support with weight management.
All care will be provided by UK-registered clinicians following a full medical assessment.
Detailed eligibility criteria and treatment pathways will be published when the clinic opens.
The Doctor’s Pharmacy is currently in a pre-launch phase and is not yet operational.
We are completing final preparation, including:
Once these steps are complete, patient registration will open.
About Us
At The Doctor’s Pharmacy, we believe that effective weight management requires careful medical assessment, ongoing clinical oversight, and decisions grounded in the best available evidence.
Our clinicians prioritise patient safety, transparency, and long-term health outcomes above all else.
Below you’ll find practical FAQs, patient guides, and clinical commentary showing how we think about weight loss.

Evidence, guidance, and clinical perspective on medical weight management.
Diet plays a central role in weight loss, but it is a complex area, and it is easy to lose sight of how the different pieces fit together.
Obesity is linked to a range of health problems, but this link is often misunderstood. It does not mean that illness is inevitable, nor does it affect everyone in the same way.
When clinicians discuss weight loss, they usually do so in a specific context: its effects on health, physiology, and future disease risk.
This miniature revolution has been driven by medications known as incretin analogues, or GLP-1 receptor agonists.
Many people have an intuitive sense that physical activity should be a key part of weight loss alongside diet.
An in-depth look at clinical trial data, interpreting findings on the long-term safety profile of GLP-1s.
Obesity is now widely understood to be a long-term, chronic disease. Body weight is regulated by biological mechanisms that act to defend a relatively stable.
Body weight falls when energy intake is lower than energy expenditure over time. That principle is straightforward. In practice, sustaining that imbalance is often difficult.
This section brings together answers to common questions about obesity, metabolic health, and medical treatment options.
Many questions are addressed within individual articles in our Knowledge Hub, where they can be explained in the appropriate clinical context. Over time, we will collate and organise the most frequently asked questions here to make them easier to find.
All FAQ content is written or reviewed by UK-registered clinicians and reflects current clinical guidance and evidence at the time of publication. Content is updated periodically as guidance and evidence evolve.
This section is intended for general information only and does not replace personalised medical advice
Diet plays a central role in weight loss, but it is a complex area, and it is easy to lose sight of how the different pieces fit together.
Obesity is linked to a range of health problems, but this link is often misunderstood. It does not mean that illness is inevitable, nor does it affect everyone in the same way.
When clinicians discuss weight loss, they usually do so in a specific context: its effects on health, physiology, and future disease risk.
This miniature revolution has been driven by medications known as incretin analogues, or GLP-1 receptor agonists.
Many people have an intuitive sense that physical activity should be a key part of weight loss alongside diet.
Body weight falls when energy intake is lower than energy expenditure over time. That principle is straightforward. In practice, sustaining that imbalance is often difficult.
An in-depth look at clinical trial data, interpreting findings on the long-term safety profile of GLP-1s.
Obesity is now widely understood to be a long-term, chronic disease. Body weight is regulated by biological mechanisms that act to defend a relatively stable.
This section will publish updates related to:
All content will be written or reviewed by UK-registered clinicians and updated in line with our Editorial Policy.
Frequently Asked Questions
All medical care and prescribing decisions are made by UK-registered doctors in line with professional and regulatory standards.
Prescribing responsibility rests with the individual clinician overseeing your care. Clinicians are registered with the General Medical Council and practise in accordance with UK medical law, professional guidance, and prescribing standards.
Clinical decisions are made on an individual basis, taking into account medical history, suitability, and safety.
Care begins with a structured online medical assessment designed to gather relevant health information, including medical history, current medications, and any factors that may affect treatment suitability.
This information is reviewed by a clinician. Treatment — including prescription medication — is only offered if it is clinically appropriate. Some patients may be advised that treatment is not suitable, or that alternative approaches should be considered.
Where treatment is initiated, care is guided by clinical judgement, response, and tolerability, with ongoing review as appropriate.
Yes. Treatments are prescribed following individual clinical assessment and in line with UK prescribing standards and accepted medical practice.
Safety considerations include medical history, contraindications, potential side effects, and the balance of risks and benefits for each patient. Dosing and treatment plans are guided by clinical response and tolerability, rather than fixed protocols alone.
Not all treatments are suitable for everyone, and medication is never prescribed automatically.
Personal and medical information is handled in accordance with UK data protection law and medical confidentiality standards.
Information provided during assessment is used solely for the purpose of delivering medical care and related administrative functions. Secure systems are used to protect patient data, and access is restricted to authorised clinical and operational staff.
Patient information is not sold or used for unrelated marketing purposes.